Acceleration of Brain Susceptibility-Weighted Imaging with Compressed Sensitivity Encoding: A Prospective Multicenter Study

References

1. 1.↵
   1. Haacke EM,
   2. Mittal S,
   3. Wu Z, et al

   . Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19–30 doi:10.3174/ajnr.A1400 pmid:19039041

   Abstract/FREE Full Text
2. 2.↵
   1. Di Ieva A,
   2. Lam T,
   3. Alcaide-Leon P, et al

   . Magnetic resonance susceptibility weighted imaging in neurosurgery: current applications and future perspectives. J Neurosurg 2015;123:1463–75 doi:10.3171/2015.1.JNS142349 pmid:26207600

   CrossRefPubMed
3. 3.↵
   1. Liu S,
   2. Buch S,
   3. Chen Y, et al

   . Susceptibility-weighted imaging: current status and future directions. NMR Biomed 2017;30:e3552 doi:10.1002/nbm.3552 pmid:27192086

   CrossRefPubMed
4. 4.↵
   1. Soman S,
   2. Bregni JA,
   3. Bilgic B, et al

   . Susceptibility-based neuroimaging: standard methods, clinical applications, and future directions. Curr Radiol Rep 2017;5:11 doi:10.1007/s40134-017-0204-1 pmid:28695062

   CrossRefPubMed
5. 5.↵
   1. Jagadeesan BD,
   2. Delgado Almandoz JE,
   3. Moran CJ, et al

   . Accuracy of susceptibility-weighted imaging for the detection of arteriovenous shunting in vascular malformations of the brain. Stroke 2011;42:87–92 doi:10.1161/STROKEAHA.110.584862 pmid:21088245

   Abstract/FREE Full Text
6. 6.↵
   1. Shen Y,
   2. Hu J,
   3. Eteer K, et al

   . Detecting sub-voxel microvasculature with USPIO-enhanced susceptibility-weighted MRI at 7 T. Magn Reson Imaging 2020;67:90–100 doi:10.1016/j.mri.2019.12.010 pmid:31911199

   CrossRefPubMed
7. 7.↵
   1. Darwish EF,
   2. Abdelhameed-El-Nouby M,
   3. Geneidy E

   . Mapping the ischemic penumbra and predicting stroke progression in acute ischemic stroke: the overlooked role of susceptibility weighted imaging. Insights Imaging 2020;11:6 doi:10.1186/s13244-019-0810-y pmid:31930428

   CrossRefPubMed
8. 8.↵
   1. Kuo JV,
   2. Huang J,
   3. Linskey ME

   . MR susceptibility-weighted imaging (SWI) complements conventional contrast enhanced imaging for melanoma gamma knife radiosurgery planning. Pract Radiat Oncol 2013;3(2 Suppl 1):S31 doi:10.1016/j.prro.2013.01.107 pmid:24674547

   CrossRefPubMed
9. 9.↵
   1. Holdsworth SJ,
   2. Yeom KW,
   3. Moseley ME, et al

   . Fast susceptibility-weighted imaging with three-dimensional short-axis propeller (SAP)-echo-planar imaging. J Magn Reson Imaging 2015;41:1447–53 doi:10.1002/jmri.24675 pmid:24956237

   CrossRefPubMed
10. 10.↵
    1. Zahneisen B,
    2. Ernst T,
    3. Poser BA

    . SENSE and simultaneous multislice imaging. Magn Reson Med 2015;74:1356–62 doi:10.1002/mrm.25519 pmid:25376715

    CrossRefPubMed
11. 11.↵
    1. Lupo JM,
    2. Banerjee S,
    3. Hammond KE, et al

    . GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T. Magn Reson Imaging 2009;27:480–88 doi:10.1016/j.mri.2008.08.003 pmid:18823730

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Wu D,
    2. Liu S,
    3. Buch S, et al

    . A fully flow-compensated multiecho susceptibility-weighted imaging sequence: the effects of acceleration and background field on flow compensation. Magn Reson Med 2016;76:478–89 doi:10.1002/mrm.25878 pmid:26332053

    CrossRefPubMed
13. 13.↵
    1. Chung MS,
    2. Lee EJ,
    3. Kim S, et al

    . Wave-CAIPI susceptibility-weighted imaging achieves diagnostic performance comparable to conventional susceptibility-weighted imaging in half the scan time. Eur Radiol 2020;30:2182–90 doi:10.1007/s00330-019-06574-1 pmid:31953660

    CrossRefPubMed
14. 14.↵
    1. Conklin J,
    2. Longo MG,
    3. Cauley SF, et al

    . Validation of highly accelerated wave-CAIPI SWI compared with conventional SWI and T2*-weighted gradient recalled-echo for routine clinical brain MRI at 3T. AJNR Am J Neuroradiol Neuroradiol 2019;40:2073–80 doi:10.3174/ajnr.A6295 pmid:31727749

    Abstract/FREE Full Text
15. 15.↵
    1. Wang N,
    2. Cofer G,
    3. Anderson RJ, et al

    . Accelerating quantitative susceptibility imaging acquisition using compressed sensing. Phys Med Biol 2018;63:245002 doi:10.1088/1361-6560/aaf15d pmid:30524114

    CrossRefPubMed
16. 16.↵
    1. Sartoretti E,
    2. Sartoretti T,
    3. Binkert C, et al

    . Reduction of procedure times in routine clinical practice with compressed SENSE magnetic resonance imaging technique. PLoS One 2019;14:e0214887 doi:10.1371/journal.pone.0214887 pmid:30978232

    CrossRefPubMed
17. 17.↵
    1. Geerts-Ossevoor L,
    2. de Weerdt E,
    3. Duijndam A, et al

    ., Compressed SENSE: Speed done right. Every time. Philips Healthcare, 2018. https://www.philips.com/c-dam/b2bhc/de/resourcecatalog/landingpages/ingeniaelition/White_Paper_Compressed_SENSE-opt.pdf. Accessed May 1, 2020
18. 18.↵
    1. Lustig M,
    2. Pauly JM

    . SPIRiT: iterative self-consistent parallel imaging reconstruction from arbitrary k-space. Magn Reson Med 2010;64:457–71 doi:10.1002/mrm.22428 pmid:20665790

    CrossRefPubMed
19. 19.↵
    1. Haller S,
    2. Haacke EM,
    3. Thurnher MM, et al

    . Susceptibility-weighted imaging: technical essentials and clinical neurologic applications. Radiology 2021;299:3–26 doi:10.1148/radiol.2021203071 pmid:33620291

    CrossRefPubMed
20. 20.↵
    1. Di Ieva A,
    2. Tschabitscher M,
    3. Galzio RJ, et al

    . The veins of the nucleus dentatus: anatomical and radiological findings. Neuroimage 2011;54:74–79 doi:10.1016/j.neuroimage.2010.07.045 pmid:20659570

    CrossRefPubMed
21. 21.↵
    1. Lewis MM,
    2. Du G,
    3. Kidacki M, et al

    . Higher iron in the red nucleus marks Parkinson’s dyskinesia. Neurobiol Aging 2013;34:1497–1503 doi:10.1016/j.neurobiolaging.2012.10.025 pmid:23177595

    CrossRefPubMed
22. 22.↵
    1. Ren Q,
    2. Meng X,
    3. Zhang B, et al

    . Morphology and signal changes of the lentiform nucleus based on susceptibility weighted imaging in parkinsonism-predominant multiple system atrophy. Parkinsonism Relat Disord 2020;81:194–99 doi:10.1016/j.parkreldis.2020.11.003 pmid:33189038

    CrossRefPubMed
23. 23.↵
    1. Altahawi FF,
    2. Blount KJ,
    3. Morley NP, et al

    . Comparing an accelerated 3D fast spin-echo sequence (CS-SPACE) for knee 3-T magnetic resonance imaging with traditional 3D fast spin-echo (SPACE) and routine 2D sequences. Skeletal Radiol 2017;46:7–15 doi:10.1007/s00256-016-2490-8 pmid:27744578

    CrossRefPubMed
24. 24.↵
    1. Ding J,
    2. Duan Y,
    3. Zhuo Z, et al

    . Acceleration of brain TOF-MRA with compressed sensitivity encoding: a multicenter clinical study. AJNR Am J Neuroradiol 2021;42:1208–15 doi:10.3174/ajnr.A7091 pmid:33858820

    Abstract/FREE Full Text
25. 25.↵
    1. Gregoire SM,
    2. Chaudhary UJ,
    3. Brown MM, et al

    . The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009;73:1759–66 doi:10.1212/WNL.0b013e3181c34a7d pmid:19933977

    Abstract/FREE Full Text
26. 26.↵
    1. Liu C,
    2. Li W,
    3. Tong KA, et al

    . Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging 2015;42:23–41 doi:10.1002/jmri.24768 pmid:25270052

    CrossRefPubMed
27. 27.↵
    1. Meijer FJ,
    2. van Rumund A,
    3. Fasen BA, et al

    . Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonism. AJNR Am J Neuroradiol 2015;36:454–60 doi:10.3174/ajnr.A4140 pmid:25339647

    Abstract/FREE Full Text
28. 28.↵
    1. Weber CE,
    2. Ebert A,
    3. Platten M, et al

    . Susceptibility-weighted 3T MRI of the swallow tail sign in multiple sclerosis: a case control study. J Neuroimaging 2020;30:766–68 doi:10.1111/jon.12775 pmid:32857891

    CrossRefPubMed
29. 29.↵
    1. Cosottini M,
    2. Frosini D,
    3. Pesaresi I, et al

    . MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. Radiology 2014;271:831–38 doi:10.1148/radiol.14131448 pmid:24601752

    CrossRefPubMed
30. 30.↵
    1. de Champfleur NM,
    2. Langlois C,
    3. Ankenbrandt WJ, et al

    . Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery 2011;68:641–47; discussion 647–48 doi:10.1227/NEU.0b013e31820773cf pmid:21164377

    CrossRefPubMed
31. 31.↵
    1. Hsu CC,
    2. Watkins TW,
    3. Kwan GN, et al

    . Susceptibility-weighted imaging of glioma: update on current imaging status and future directions. J Neuroimaging 2016;26:383–90 doi:10.1111/jon.12360 pmid:27227542

    CrossRefPubMed
32. 32.↵
    1. Ma X,
    2. Bai Y,
    3. Lin Y, et al

    . Amide proton transfer magnetic resonance imaging in detecting intracranial hemorrhage at different stages: a comparative study with susceptibility weighted imaging. Sci Rep 2017;7:45696 doi:10.1038/srep45696 pmid:28374764

    CrossRefPubMed
33. 33.↵
    1. Lupo JM,
    2. Banerjee S,
    3. Kelley D, et al

    . Partially-parallel, susceptibility-weighted MR imaging of brain vasculature at 7 Tesla using sensitivity encoding and an autocalibrating parallel technique. Conf Proc IEEE Eng Med Biol Soc 2006;2006:747–50 doi:10.1109/IEMBS.2006.259807 pmid:17945996

    CrossRefPubMed